Phil, Inc. · 15 hours ago
Head of UX Design
Maximize your interview chances
Insider Connection @Phil, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Define and lead the design strategy for internal operations tools, optimizing workflows for quality and efficiency.
Collaborate with pharmacists and internal stakeholders to gather insights and translate them into user-friendly software solutions.
Lead the design of patient-facing experiences that enhance ease of use and accessibility.
Work with product and engineering teams to execute the design roadmap and ensure smooth implementation.
Champion user-centered design and foster a design-thinking culture within the organization, including service blueprinting.
Track and report on key performance metrics related to operational quality and patient experience.
Oversee design from research through execution, ensuring top-quality outcomes.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
A passion for helping patients and a get-it-done approach
5+ years in a design leadership role, with experience in internal operations tools.
Proven ability to design complex software with multiple stakeholders.
Skilled in balancing internal and patient-facing design needs.
Strong portfolio demonstrating user-centered design across different platforms.
Preferred
Relevant educational background
Benefits
Ground floor opportunity with one of the fastest-growing healthtech startups
Competitive compensation including stock options
Full benefits (medical, dental, vision)
401(k) contribution opportunity
Solving a problem that matters
Company
Phil, Inc.
Phil helps retail and specialty-lite brands accelerate patient access, provider engagement, and brand outcomes through technology.
Funding
Current Stage
Growth StageTotal Funding
$121.61MKey Investors
Warburg PincusTarsadia InvestmentsGreatPoint Ventures
2021-11-17Pre Seed· undefined
2021-06-03Series D· $56M
2021-03-30Series C· $23M
Recent News
2024-06-04
2024-06-03
Company data provided by crunchbase